PAVmed, Inc. (PAVM)
5.14
+0.04
(+0.78%)
USD |
NASDAQ |
Aug 25, 11:40
PAVmed Shareholders Equity (Quarterly) : 35.05M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.05M |
| March 31, 2026 | 39.52M |
| December 31, 2025 | 33.97M |
| September 30, 2025 | 35.78M |
| June 30, 2025 | 40.79M |
| March 31, 2025 | 46.99M |
| December 31, 2024 | -2.495M |
| September 30, 2024 | -4.869M |
| June 30, 2024 | -73.94M |
| March 31, 2024 | -68.78M |
| December 31, 2023 | -53.83M |
| September 30, 2023 | -43.26M |
| June 30, 2023 | -31.51M |
| March 31, 2023 | -22.06M |
| December 31, 2022 | -9.681M |
| September 30, 2022 | 8.948M |
| June 30, 2022 | 21.98M |
| March 31, 2022 | 45.93M |
| December 31, 2021 | 61.67M |
| September 30, 2021 | 34.87M |
| June 30, 2021 | 42.95M |
| March 31, 2021 | 50.29M |
| December 31, 2020 | 1.896M |
| Date | Value |
|---|---|
| September 30, 2020 | -12.90M |
| June 30, 2020 | -11.32M |
| March 31, 2020 | -15.00M |
| December 31, 2019 | -3.824M |
| September 30, 2019 | -1.886M |
| June 30, 2019 | -1.536M |
| March 31, 2019 | -5.443M |
| December 31, 2018 | -2.315M |
| September 30, 2018 | 3.654M |
| June 30, 2018 | 6.594M |
| March 31, 2018 | 0.2478M |
| December 31, 2017 | -2.848M |
| September 30, 2017 | -5.913M |
| June 30, 2017 | -5.050M |
| March 31, 2017 | -4.314M |
| December 31, 2016 | -0.3191M |
| September 30, 2016 | 1.144M |
| June 30, 2016 | 2.749M |
| March 31, 2016 | -0.063M |
| December 31, 2015 | 0.6339M |
| September 30, 2015 | 1.571M |
| June 30, 2015 | 0.4879M |
| March 31, 2015 | 0.7485M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.21M |
| Total Liabilities (Quarterly) | 20.91M |
| Debt to Equity Ratio | 0.487 |
| Current Ratio | 1.188 |
| Net Debt Paydown Yield | -4.21% |